Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial to Compare the Efficacy of Angiolite Stent Versus a Second-generation Drug-eluting Stent Such as Xience in Patients With Indication of Percutaneous Coronary Intervention

NCT03049657 is registered in ClinicalTrials.gov with Cardiva2 S.L. as lead sponsor.

NCT NCT03049657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03049657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial to Compare the Efficacy of Angiolite Stent Versus a Second-generation Drug-eluting Stent Such as Xience in Patients With Indication of Percutaneous Coronary Intervention
Lead sponsor
Cardiva2 S.L.
Phase
Not applicable
Overall status
Completed
Start date
February 2, 2016
Completion date
January 28, 2019
Enrollment
220 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, drug-eluting stent